These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23241421)

  • 1. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.
    Yi J; Gwak GY; Sinn DH; Kim YJ; Kim HN; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2013; 60(122):328-32. PubMed ID: 23241421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
    Lee HS
    Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of hepatocellular carcinoma with extrahepatic metastases.
    Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma.
    Jin YJ; Lee HC; Lee D; Shim JH; Kim KM; Lim YS; Do KH; Ryu JS
    J Hepatol; 2012 Jun; 56(6):1324-9. PubMed ID: 22322236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.
    Ariizumi S; Katagiri S; Katsuragawa H; Kotera Y; Yamamoto M
    Dig Surg; 2007; 24(5):342-8. PubMed ID: 17785977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of T3/4 and regional lymph nodes in gallbladder cancer: which is more valid, the UICC or the Japanese staging system?
    Kishi Y; Shimada K; Hata S; Oguro S; Sakamoto Y; Nara S; Esaki M; Hiraoka N; Kosuge T
    Ann Surg Oncol; 2012 Oct; 19(11):3567-73. PubMed ID: 22890597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
    Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M
    Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection.
    Chiappa A; Zbar AP; Podda M; Audisio RA; Bertani E; Biella F; Paties C; Staudacher C
    Hepatogastroenterology; 2001; 48(37):229-34. PubMed ID: 11268972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy].
    Li BK; Cui BK; Yuan YF; Li JQ; Zhang YQ; Shi M; Li GH
    Ai Zheng; 2005 Jul; 24(7):769-73. PubMed ID: 16004798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.
    Jun L; Zhenlin Y; Renyan G; Yizhou W; Xuying W; Feng X; Yong X; Kui W; Jian L; Dong W; Hongyang W; Lehua S; Mengchao W; Feng S
    Oncologist; 2012; 17(7):963-9. PubMed ID: 22653882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
    Talbot JN; Fartoux L; Balogova S; Nataf V; Kerrou K; Gutman F; Huchet V; Ancel D; Grange JD; Rosmorduc O
    J Nucl Med; 2010 Nov; 51(11):1699-706. PubMed ID: 20956466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
    Levi DM; Tzakis AG; Martin P; Nishida S; Island E; Moon J; Selvaggi G; Tekin A; Madrazo BL; Narayanan G; Garcia MT; Feun LG; Tryphonopoulos P; Skartsis N; Livingstone AS
    J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pittsburgh modified TNM criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma.
    Chen J; Xu X; Ling Q; Wu J; Zheng SS
    Chin Med J (Engl); 2007 Dec; 120(24):2200-3. PubMed ID: 18167202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
    Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
    Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.